Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

aspire pharma ltd - paracetamol - suppository - 250mg

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - paracetamol - suppository - 250mg

Irland - engelsk - HPRA (Health Products Regulatory Authority)

przedsiebiorstwo farmaceutyczne jelfa s.a. - latanoprost timolol maleate - eye drops solution - 50+5

Malta - engelsk - Medicines Authority

przedsiebiorstwo farmaceutyczne lek-am sp. z o.o 14a ostrzykowizna street, 05-170 zakroczym, , poland - sunitinib - hard capsule - sunitinib 12.5 mg - antineoplastic agents

Malta - engelsk - Medicines Authority

przedsiebiorstwo farmaceutyczne lek-am sp. z o.o 14a ostrzykowizna street, 05-170 zakroczym, , poland - sunitinib - hard capsule - sunitinib 25 mg - antineoplastic agents

Malta - engelsk - Medicines Authority

przedsiebiorstwo farmaceutyczne lek-am sp. z o.o 14a ostrzykowizna street, 05-170 zakroczym, , poland - sunitinib - hard capsule - sunitinib 50 mg - antineoplastic agents

Den europeiske union - engelsk - EMA (European Medicines Agency)

"anpharm" przedsiębiorstwo farmaceutyczne s.a. - ivabradine - angina pectoris; heart failure - other cardiac preparations - symptomatic treatment of chronic stable angina pectorisivabradine is indicated for the symptomatic treatment of chronic stable angina pectoris in coronary artery disease adults with normal sinus rhythm and heart rate ≥ 70 bpm. ivabradine is indicated:in adults unable to tolerate or with a contra-indication to the use of beta-blockersor in combination with beta-blockers in patients inadequately controlled with an optimal betablocker dose.treatment of chronic heart failureivabradine is indicated in chronic heart failure nyha ii to iv class with systolic dysfunction, in patients in sinus rhythm and whose heart rate is ≥ 75 bpm, in combination with standard therapy including beta-blocker therapy or when beta-blocker therapy is contraindicated or not tolerated.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

minus110 pty ltd - 45140 - cryotherapy set - cryogenic chamber - ( cryochamber) ? is suited for group systemic cryogenic therapy. cryochamber is a unit composed of two separate rooms ? the preliminary chamber and the main chamber. the temperature may be set ranging from -40c to -60c in the preliminary chamber and from -100c to -160c in the main chamber. the time of the procedure is set and controlled by the personnel and equals 3 minutes for each chamber. both ,treatment temperatures and time may be selected and planned individually for each and every session. induced circulation on ?cold? enables an even spread of temperature throughout the rooms. furthermore the lack of roof eliminates the problem of heat produced by patients which accumulates under the ceiling. in chamber equipped with roofs the accumulated heat has a negative effect on the distribution of temperature within the area of both chambers the advantages of our cryochamber : - relatively low investment costs - low operational costs - low usage of cryogenic gas -

Malta - engelsk - Medicines Authority

les laboratoires servier 50 rue carnot, 92284 suresnes cedex, france - atorvastatin calcium, trihydrate, perindopril arginine - hard capsule - atorvastatin calcium trihydrate 10.82 mg perindopril arginine 5 mg - lipid modifying agents

Malta - engelsk - Medicines Authority

les laboratoires servier 50 rue carnot, 92284 suresnes cedex, france - atorvastatin calcium, trihydrate, perindopril arginine - hard capsule - atorvastatin calcium trihydrate 21.64 mg perindopril arginine 5 mg - lipid modifying agents